Global Information
회사소개 | 문의 | 비교리스트

세계의 혈장 분획 시장 분석과 예측(2016-2027년)

Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027

리서치사 QYResearch
발행일 2022년 06월 상품코드 1062732
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 3,350 ₩ 4,400,000 PDF (Single User License)
US $ 5,025 ₩ 6,600,000 PDF (Multi User License)
US $ 6,700 ₩ 8,801,000 PDF (Enterprise User License)


세계의 혈장 분획 시장 분석과 예측(2016-2027년) Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027
발행일 : 2022년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 혈장 분획 시장 규모는 2020년에 263억 8,400만 달러로 평가되었습니다.

2021-2027년간 시장은 7.63%의 연평균 복합 성장률(CAGR)로 확대되어 2027년 말까지 440억 3,400만 달러에 달할 것으로 예측됩니다.

세계의 혈장 분획(Blood Plasma Fractionation) 시장에 대해 조사했으며, 시장 규모와 예측, 유형·용도·기업·지역별 시장 분석, 시장 역학, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 혈장 분획 시장 개요

  • 혈장 분획 제품 개요
  • 유형별 : 시장 부문
    • 알부민
    • 면역글로불린
    • 응고인자
  • 유형별 : 시장 규모
    • 시장 규모 개요(2016-2027년)
    • 시장 규모 실적 리뷰(2016-2021년)
    • 시장 규모 예측(2022-2027년)
  • 유형별 주요 지역 시장 규모 부문
    • 북미의 판매량 분석(2016-2021년)
    • 유럽의 판매량 분석(2016-2021년)
    • 아시아태평양의 판매량 분석(2016-2021년)
    • 남미의 판매량 분석(2016-2021년)
    • 중동 및 아프리카의 판매량 분석(2016-2021년)

제2장 기업별 : 혈장 분획 시장 경쟁

  • 판매량별 : 주요 기업(2019-2021년)
  • 매출별 : 주요 기업(2019-2021년)
  • 가격별 : 주요 기업(2019-2021년)
  • 주요 제조업체의 제조거점, 판매 지역, 제품 유형
  • 시장 경쟁 구도와 동향
  • 기업 유형별(Tier 1, Tier 2, Tier 3) : 세계의 주요 제조업체(2020년 기준 매출에 근거)
  • 주요 제조업체의 설립일
  • 주요 제조업체의 제공 제품
  • 인수합병(M&A) 및 사업 확장

제3장 지역별 : 혈장 분획 상황과 전망

  • 지역별 : 시장 규모와 CAGR : 2016년 vs. 2021년 vs. 2026년
  • 지역별 : 시장 규모 실적
  • 지역별 : 시장 규모

제4장 용도별 : 혈장 분획

  • 용도별 : 시장 부문
    • 병원
    • 소매 약국
  • 용도별 : 시장 규모
    • 시장 규모 개요(2016-2027년)
    • 시장 규모 실적 리뷰(2016-2021년)
    • 시장 규모 예측(2022-2027년)
  • 용도별 : 주요 지역 시장 규모 부문
    • 북미의 매출 분석(2016-2021년)
    • 유럽의 매출 분석(2016-2021년)
    • 아시아태평양의 매출 분석(2016-2021년)
    • 남미의 매출 분석(2016-2021년)
    • 중동 및 아프리카의 매출 분석(2016-2021년)

제5장 국가별 : 북미의 혈장 분획

  • 국가별 : 시장 규모 실적
  • 국가별 : 시장 규모 예측

제6장 국가별 : 유럽의 혈장 분획

  • 국가별 : 시장 규모 실적
  • 국가별 : 시장 규모 예측

제7장 지역별 : 아시아태평양의 혈장 분획

  • 지역별 : 시장 규모 실적
  • 지역별 : 시장 규모 예측

제8장 남미의 혈장 분획

  • 국가별 : 시장 규모 실적
  • 국가별 : 시장 규모 예측

제9장 국가별 : 중동 및 아프리카의 혈장 분획

  • 국가별 : 시장 규모 실적
  • 국가별 : 시장 규모 예측

제10장 혈장 분획 사업 기업 개요와 주요 데이터

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

제11장 업스트림(Upstream) 부문, 기회, 과제, 리스크 및 영향요인 분석

  • 주요 원재료
  • 제조 원가 구조
  • 제조 공정 분석
  • 산업 체인 분석
  • 시장 역학
    • 업계 동향
    • 성장 촉진요인
    • 시장이 해결해야 할 과제
    • 성장 억제요인

제12장 마케팅 전략 분석, 유통업체

  • 판매 채널
  • 유통업체
  • 다운스트림(Downstream) 부문 고객

제13장 조사 결과와 결론

제14장 부록

LSH 22.03.11

LIST OF TABLES

  • Table 1. Global Blood Plasma Fractionation Sales by Type: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 2. Global Blood Plasma Fractionation Sales by Type (2016-2021) & (K Unit)
  • Table 3. Global Blood Plasma Fractionation Sales Market Share in Volume by Type (2016-2021)
  • Table 4. Global Blood Plasma Fractionation Sales by Type (2016-2021) & (US$ Million)
  • Table 5. Global Blood Plasma Fractionation Sales Market Share in Value by Type (2016-2021)
  • Table 6. Global Blood Plasma Fractionation Price by Type (2016-2021) & (USD/Unit)
  • Table 7. Global Blood Plasma Fractionation Sales by Type (2022-2027) & (K Unit)
  • Table 8. Global Blood Plasma Fractionation Sales Market Share in Volume by Type (2022-2027)
  • Table 9. Global Blood Plasma Fractionation Sales by Type (2022-2027) & (US$ Million)
  • Table 10. Global Blood Plasma Fractionation Sales Market Share in Value by Type (2022-2027)
  • Table 11. Global Blood Plasma Fractionation Price by Type (2022-2027) & (USD/Unit)
  • Table 12. North America Blood Plasma Fractionation Sales by Type (2016-2021) & (K Unit)
  • Table 13. North America Blood Plasma Fractionation Sales by Type (2016-2021) & (US$ Million)
  • Table 14. Europe Blood Plasma Fractionation Sales (K Unit) by Type (2016-2021)
  • Table 15. Europe Blood Plasma Fractionation Sales by Type (2016-2021) & (US$ Million)
  • Table 16. Asia-Pacific Blood Plasma Fractionation Sales (K Unit) by Type (2016-2021)
  • Table 17. Asia-Pacific Blood Plasma Fractionation Sales by Type (2016-2021) & (US$ Million)
  • Table 18. South America Blood Plasma Fractionation Sales (K Unit) by Type (2016-2021)
  • Table 19. South America Blood Plasma Fractionation Sales by Type (2016-2021) & (US$ Million)
  • Table 20. Middle East and Africa Blood Plasma Fractionation Sales (K Unit) by Type (2016-2021)
  • Table 21. Middle East and Africa Blood Plasma Fractionation Sales by Type (2016-2021) & (US$ Million)
  • Table 22. Global Blood Plasma Fractionation Sales by Company (2019-2021) & (K Unit)
  • Table 23. Global Blood Plasma Fractionation Sales Share by Company (2019-2021)
  • Table 24. Global Blood Plasma Fractionation Revenue by Company (2019-2021) & (US$ Million)
  • Table 25. Global Blood Plasma Fractionation Revenue Share by Company (2016-2021)
  • Table 26. Global Market Blood Plasma Fractionation Price by Company (2019-2021) & (USD/Unit)
  • Table 27. Global Blood Plasma Fractionation Top Manufacturers Manufacturing Base Distribution and Headquarters
  • Table 28. Global Blood Plasma Fractionation Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2020)
  • Table 30. Founded Date of Key Blood Plasma Fractionation Manufacturers
  • Table 31. Key Manufacturers Blood Plasma Fractionation Product Type
  • Table 32. Mergers & Acquisitions, Expansion Plans
  • Table 33. Global Blood Plasma Fractionation Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
  • Table 34. Global Blood Plasma Fractionation Sales by Region (2016-2021) & (K Unit)
  • Table 35. Global Blood Plasma Fractionation Sales Market Share in Volume by Region (2016-2021)
  • Table 36. Global Blood Plasma Fractionation Sales by Region (2016-2021) & (US$ Million)
  • Table 37. Global Blood Plasma Fractionation Sales Market Share in Value by Region (2016-2021)
  • Table 38. Global Blood Plasma Fractionation Sales (K Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
  • Table 39. Global Blood Plasma Fractionation Sales by Region (2022-2027) & (K Unit)
  • Table 40. Global Blood Plasma Fractionation Sales Market Share in Volume by Region (2022-2027)
  • Table 41. Global Blood Plasma Fractionation Sales by Region (2022-2027) & (US$ Million)
  • Table 42. Global Blood Plasma Fractionation Sales Market Share in Value by Region (2022-2027)
  • Table 43. Global Blood Plasma Fractionation Sales (K Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027)
  • Table 44. Global Blood Plasma Fractionation Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 45. Global Blood Plasma Fractionation Sales by Application (2016-2021) & (K Unit)
  • Table 46. Global Blood Plasma Fractionation Sales Market Share in Volume by Application (2016-2021)
  • Table 47. Global Blood Plasma Fractionation Sales by Application (2016-2021) & (US$ Million)
  • Table 48. Global Blood Plasma Fractionation Sales Market Share in Value by Application (2016-2021)
  • Table 49. Global Blood Plasma Fractionation Price by Application (2016-2021) & (USD/Unit)
  • Table 50. Global Blood Plasma Fractionation Sales by Application (2022-2027) & (K Unit)
  • Table 51. Global Blood Plasma Fractionation Sales Market Share in Volume by Application (2022-2027)
  • Table 52. Global Blood Plasma Fractionation Sales by Application (2022-2027) & (US$ Million)
  • Table 53. Global Blood Plasma Fractionation Sales Market Share in Value by Application (2022-2027)
  • Table 54. Global Blood Plasma Fractionation Sales Market Share in Value by Application (2022-2027)
  • Table 55. Global Blood Plasma Fractionation Price by Application (2022-2027) & (USD/Unit)
  • Table 56. North America Blood Plasma Fractionation Revenue by Application (2016-2021) & (US$ Million)
  • Table 57. North America Blood Plasma Fractionation Sales Market Share in Value by Application in 2026-2021
  • Table 58. Europe Blood Plasma Fractionation Revenue by Application (2016-2021) & (US$ Million)
  • Table 59. Asia-Pacific Blood Plasma Fractionation Revenue by Application (2016-2021) & (US$ Million)
  • Table 60. South America Blood Plasma Fractionation Revenue by Application (2016-2021) & (US$ Million)
  • Table 61. Middle East and Africa Blood Plasma Fractionation Revenue by Application (2016-2021) & (US$ Million)
  • Table 62. North America Blood Plasma Fractionation Sales by Country (2016-2021) & (K Unit)
  • Table 63. North America Blood Plasma Fractionation Sales Market Share in Volume by Country (2016-2021)
  • Table 64. North America Blood Plasma Fractionation Sales by Country (2016-2021) & (US$ Million)
  • Table 65. North America Blood Plasma Fractionation Sales Market Share in Value by Country (2016-2021)
  • Table 66. North America Blood Plasma Fractionation Sales by Country (2022-2027) & (K Unit)
  • Table 67. North America Blood Plasma Fractionation Sales Market Share in Volume by Country (2022-2027)
  • Table 68. North America Blood Plasma Fractionation Sales by Country (2022-2027) & (US$ Million)
  • Table 69. North America Blood Plasma Fractionation Sales Market Share in Value by Country (2022-2027)
  • Table 70. Europe Blood Plasma Fractionation Sales by Country (2016-2021) & (K Unit)
  • Table 71. Europe Blood Plasma Fractionation Sales Market Share in Volume by Country (2016-2021)
  • Table 72. Europe Blood Plasma Fractionation Sales by Country (2016-2021) & (US$ Million)
  • Table 73. Europe Blood Plasma Fractionation Sales Market Share in Value by Country (2016-2021)
  • Table 74. Europe Blood Plasma Fractionation Sales by Country (2022-2027) & (K Unit)
  • Table 75. Europe Blood Plasma Fractionation Sales Market Share in Volume by Country (2022-2027)
  • Table 76. Europe Blood Plasma Fractionation Sales by Country (2022-2027) & (US$ Million)
  • Table 77. Europe Blood Plasma Fractionation Sales Market Share in Value by Country (2022-2027)
  • Table 78. Asia-Pacific Blood Plasma Fractionation Sales by Region (2016-2021) & (K Unit)
  • Table 79. Asia-Pacific Blood Plasma Fractionation Sales Market Share in Volume by Region (2016-2021)
  • Table 80. Asia-Pacific Blood Plasma Fractionation Sales by Region (2016-2021) & (US$ Million)
  • Table 81. Asia-Pacific Blood Plasma Fractionation Sales Market Share in Value by Region (2016-2021)
  • Table 82. Asia-Pacific Blood Plasma Fractionation Sales by Region (2022-2027) & (K Unit)
  • Table 83. Asia-Pacific Blood Plasma Fractionation Sales Market Share in Volume by Region (2022-2027)
  • Table 84. Asia-Pacific Blood Plasma Fractionation Sales by Region (2022-2027) & (US$ Million)
  • Table 85. Asia-Pacific Blood Plasma Fractionation Sales Market Share in Value by Region (2022-2027)
  • Table 86. South America Blood Plasma Fractionation Sales by Country (2016-2021) & (K Unit)
  • Table 87. South America Blood Plasma Fractionation Sales Market Share in Volume by Country (2016-2021)
  • Table 88. South America Blood Plasma Fractionation Sales by Country (2016-2021) & (US$ Million)
  • Table 89. South America Blood Plasma Fractionation Sales Market Share in Value by Country (2016-2021)
  • Table 90. South America Blood Plasma Fractionation Sales by Country (2022-2027) & (K Unit)
  • Table 91. South America Blood Plasma Fractionation Sales Market Share in Volume by Country (2022-2027)
  • Table 92. South America Blood Plasma Fractionation Sales by Country (2022-2027) & (US$ Million)
  • Table 93. South America Blood Plasma Fractionation Sales Market Share in Value by Country (2022-2027)
  • Table 94. Middle East and Africa Blood Plasma Fractionation Sales by Country (2016-2021) & (K Unit)
  • Table 95. Middle East and Africa Blood Plasma Fractionation Sales Market Share in Volume by Country (2016-2021)
  • Table 96. Middle East and Africa Blood Plasma Fractionation Sales by Country (2016-2021) & (US$ Million)
  • Table 97. Middle East and Africa Blood Plasma Fractionation Sales Market Share in Value by Country (2016-2021)
  • Table 98. Middle East and Africa Blood Plasma Fractionation Sales by Country (2022-2027) & (K Unit)
  • Table 99. Middle East and Africa Blood Plasma Fractionation Sales Market Share by Country (2022-2027)
  • Table 100. Middle East and Africa Blood Plasma Fractionation Sales by Country (2022-2027) & (US$ Million)
  • Table 101. Middle East and Africa Blood Plasma Fractionation Sales Market Share in Value by Country (2022-2027)
  • Table 102. Takeda Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 103. Takeda Blood Plasma Fractionation Product Offered
  • Table 104. Takeda Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 105. Takeda Latest Developments
  • Table 106. CSL Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 107. CSL Blood Plasma Fractionation Product Offered
  • Table 108. CSL Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 109. CSL Latest Developments
  • Table 110. Grifols Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 111. Grifols Blood Plasma Fractionation Product Offered
  • Table 112. Grifols IVIG Flebogamma® 10% DIF Packaging Standards
  • Table 113. Grifols IVIG Flebogamma® 5% DIF Packaging Standards
  • Table 114. Grifols Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 115. Grifols Latest Developments
  • Table 116. Octapharma Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 117. Octapharma Blood Plasma Fractionation Product Offered
  • Table 118. Octapharma Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 119. Octapharma Latest Developments
  • Table 120. Kedrion Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 121. Kedrion Blood Plasma Fractionation Product Offered
  • Table 122. Kedrion Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 123. LFB Group Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 124. LFB Group Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 125. Biotest Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 126. Biotest Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 127. BPL Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 128. BPL Blood Plasma Fractionation Product Offered
  • Table 129. BPL Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 130. BPL Latest Developments
  • Table 131. RAAS Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 132. RAAS Blood Plasma Fractionation Product Offered
  • Table 133. RAAS Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 134. RAAS Latest Developments
  • Table 135. CBPO Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 136. CBPO Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 137. CBPO Latest Developments
  • Table 138. Hualan Bio Basic Information, Blood Plasma Fractionation Headquarters, Sales Area
  • Table 139. Hualan Bio Blood Plasma Fractionation Product Offered
  • Table 140. Hualan Bio IVIG Standards
  • Table 141. Specifications of Albumin Product
  • Table 142. Hualan Bio Blood Plasma Fractionation Sales (K Unit), Revenue ($ Million) and Gross Margin (2019-2021E)
  • Table 143. Tiantan Bio Corporation Information
  • Table 144. Tiantan Bio Blood Plasma Fractionation Product
  • Table 145. Tiantan Bio Blood Plasma Fractionation Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 146. Shuanglin Bio Corporation Information
  • Table 147. Shuanglin Bio Blood Plasma Fractionation Product
  • Table 148. Shuanglin Bio Blood Plasma Fractionation Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 149. Boya Bio Corporation Information
  • Table 150. Boya Bio Blood Plasma Fractionation Product
  • Table 151. Boya Bio Blood Plasma Fractionation Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 152. Yuanda Shuyang Corporation Information
  • Table 153. Yuanda Shuyang Blood Plasma Fractionation Product
  • Table 154. Yuanda Shuyang Blood Plasma Fractionation Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 155. Weiguang Bio Corporation Information
  • Table 156. Weiguang Bio Blood Plasma Fractionation Product
  • Table 157. Weiguang Bio Blood Plasma Fractionation Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 158. Nanyue Bio Corporation Information
  • Table 159. Nanyue Bio Blood Plasma Fractionation Product
  • Table 160. Nanyue Bio Blood Plasma Fractionation Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 161. KM Biologics Corporation Information
  • Table 162. KM Biologics Blood Plasma Fractionation Product
  • Table 163. KM Biologics Blood Plasma Fractionation Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 164. KM Biologics Recent Development
  • Table 165. Key Raw Materials Lists
  • Table 166. Global Blood Plasma Fractionation Capacity (M L), Throughput (M L) and Utilization Rate by Region in 2020
  • Table 167. Plasma: Cost Components
  • Table 168. Raw Materials Key Suppliers Lists
  • Table 169. Key Transactions in the Blood Plasma Fractionation Industry 1997'2019 (Market Trends)
  • Table 170. Blood Plasma Fractionation Market Drivers
  • Table 171. Blood Plasma Fractionation Market Challenges
  • Table 172. Blood Plasma Fractionation Market Restraints
  • Table 173. Blood Plasma Fractionation Distributors List
  • Table 174. Blood Plasma Fractionation Downstream Customers
  • Table 175. Research Programs/Design for This Report
  • Table 176. Key Data Information from Secondary Sources
  • Table 177. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Constituents of Blood, Plasma, and Plasma Proteins
  • Figure 2. Blood Plasma Fractionation Product Picture
  • Figure 3. Global Blood Plasma Fractionation Market Size, 2016 VS 2021 VS 2027 (US$ Million)
  • Figure 4. Global Blood Plasma Fractionation Market Size Status and Outlook (2016-2027) & (US$ Million)
  • Figure 5. Global Blood Plasma Fractionation Sales Status and Outlook (2016-2027) & (K Unit)
  • Figure 6. Product Picture of Albumin
  • Figure 7. Global Albumin Sales YoY Growth (2016-2027) & (K Unit)
  • Figure 8. Product Picture of Immune Globulin
  • Figure 9. Global Immune Globulin Sales YoY Growth (2016-2027) & (K Unit)
  • Figure 10. Product Picture of Coagulation Factor
  • Figure 11. Global Coagulation Factor Sales YoY Growth (2016-2027) & (K Unit)
  • Figure 12. Global Blood Plasma Fractionation Sales by Type (2016-2027) & (US$ Million)
  • Figure 13. Global Blood Plasma Fractionation Sales Market Share in Volume by Type (2016-2021)
  • Figure 14. Global Blood Plasma Fractionation Sales Market Share in Value by Type (2016-2021)
  • Figure 15. Global Blood Plasma Fractionation Sales Market Share in Volume by Type (2022-2027)
  • Figure 16. Global Blood Plasma Fractionation Sales Market Share in Value by Type (2022-2027)
  • Figure 17. North America Blood Plasma Fractionation Sales Market Share in Volume by Type in 2020
  • Figure 18. North America Blood Plasma Fractionation Sales Market Share in Value by Type in 2020
  • Figure 19. Europe Blood Plasma Fractionation Sales Market Share in Volume by Type in 2020
  • Figure 20. Europe Blood Plasma Fractionation Sales Market Share in Value by Type in 2020
  • Figure 21. Asia-Pacific Blood Plasma Fractionation Sales Market Share in Volume by Type in 2020
  • Figure 22. Asia-Pacific Blood Plasma Fractionation Sales Market Share in Value by Type in 2020
  • Figure 23. South America Blood Plasma Fractionation Sales Market Share in Volume by Type in 2020
  • Figure 24. South America Blood Plasma Fractionation Sales Market Share in Value by Type in 2020
  • Figure 25. Middle East and Africa Blood Plasma Fractionation Sales Market Share in Volume by Type in 2020
  • Figure 26. Middle East and Africa Blood Plasma Fractionation Sales Market Share in Value by Type in 2020
  • Figure 27. The 5 Largest Manufacturers in the World: Market Share by Blood Plasma Fractionation Sales in 2020
  • Figure 28. The 5 Largest Manufacturers in the World: Market Share by Blood Plasma Fractionation Revenue in 2020
  • Figure 29. Product Picture of Hospital
  • Figure 30. Global Hospital Sales YoY Growth (2016-2027) & (K Unit)
  • Figure 31. Product Picture of Retail Pharmacy
  • Figure 32. Global Retail Pharmacy Sales YoY Growth (2016-2027) & (K Unit)
  • Figure 33. Global Blood Plasma Fractionation Sales by Application (2016-2027) & (US$ Million)
  • Figure 34. Global Blood Plasma Fractionation Sales Market Share in Volume by Application (2016-2021)
  • Figure 35. Global Blood Plasma Fractionation Sales Market Share in Value by Application (2016-2021)
  • Figure 36. Global Blood Plasma Fractionation Sales Market Share in Volume by Application (2022-2027)
  • Figure 37. Europe Blood Plasma Fractionation Sales Market Share in Value by Application in 2020
  • Figure 38. Asia-Pacific Blood Plasma Fractionation Sales Market Share in Value by Application in 2020
  • Figure 39. South America Blood Plasma Fractionation Sales Market Share in Value by Application in 2026-2021
  • Figure 40. Middle East and Africa Blood Plasma Fractionation Sales Market Share in Value by Application in 2016-2021
  • Figure 41. LFB Group Blood Plasma Fractionation Product Offered
  • Figure 42. Biotest Blood Plasma Fractionation Product Offered
  • Figure 43. CBPO Blood Plasma Fractionation Product Offered
  • Figure 44. Diagram of Automated Plasma Collection Procedure
  • Figure 45. Blood Plasma Fractionation Manufacturing Cost Structure
  • Figure 46. Manufacturing Process Analysis of Blood Plasma Fractionation
  • Figure 47. Main Product Separation Sequence of Blood Products during the Separation Process
  • Figure 48. Blood Plasma Fractionation Industrial Chain Analysis
  • Figure 49. Channels of Distribution
  • Figure 50. Distributors Profiles
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed

Market Analysis and Insights:

In 2020, the global Blood Plasma Fractionation market size was US$ 26384 million and it is expected to reach US$ 44034 million by the end of 2027, with a CAGR of 7.63% between 2021 and 2027.

Scope and Market Size:

The global Blood Plasma Fractionation market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Blood Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

By Company

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Segment by Type

  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Other

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • South America
    • Brazil
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 BLOOD PLASMA FRACTIONATION MARKET OVERVIEW

  • 1.1 Blood Plasma Fractionation Product Overview
  • 1.2 Blood Plasma Fractionation Market Segment by Type
    • 1.2.1 Albumin
    • 1.2.2 Immune Globulin
    • 1.2.3 Coagulation Factor
  • 1.3 Global Blood Plasma Fractionation Market Size by Type
    • 1.3.1 Global Blood Plasma Fractionation Market Size Overview by Type (2016-2027)
    • 1.3.2 Global Blood Plasma Fractionation Historic Market Size Review by Type (2016-2021)
      • 1.3.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Type (2016-2021)
      • 1.3.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Type (2016-2021)
      • 1.3.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2016-2021)
    • 1.3.3 Global Blood Plasma Fractionation Forecasted Market Size by Type (2022-2027)
      • 1.3.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Type (2022-2027)
      • 1.3.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Type (2022-2027)
      • 1.3.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2022-2027)
  • 1.4 Key Regions Market Size Segment by Type
    • 1.4.1 North America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
    • 1.4.2 Europe Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
    • 1.4.3 Asia-Pacific Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
    • 1.4.4 South America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
    • 1.4.5 Middle East and Africa Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)

2 BLOOD PLASMA FRACTIONATION MARKET COMPETITION BY COMPANY

  • 2.1 Global Top Players by Blood Plasma Fractionation Sales (2019-2021)
  • 2.2 Global Top Players by Blood Plasma Fractionation Revenue (2019-2021)
  • 2.3 Global Top Players by Blood Plasma Fractionation Price (2019-2021)
  • 2.4 Global Top Manufacturers Blood Plasma Fractionation Manufacturing Base Distribution, Sales Area, Product Type
  • 2.5 Blood Plasma Fractionation Market Competitive Situation and Trends
    • 2.5.1 Blood Plasma Fractionation Market Concentration Rate (2019-2021)
    • 2.5.2 Global 5 Largest Manufacturers by Blood Plasma Fractionation Sales and Revenue in 2020
  • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2020)
  • 2.7 Founded Date of Key Blood Plasma Fractionation Manufacturers
  • 2.8 Key Manufacturers Blood Plasma Fractionation Product Offered
  • 2.9 Mergers & Acquisitions, Expansion

3 BLOOD PLASMA FRACTIONATION STATUS AND OUTLOOK BY REGION

  • 3.1 Global Blood Plasma Fractionation Market Size and CAGR by Region: 2016 VS 2021 VS 2026
  • 3.2 Global Blood Plasma Fractionation Historic Market Size by Region
    • 3.2.1 Global Blood Plasma Fractionation Sales in Volume by Region (2016-2021)
    • 3.2.2 Global Blood Plasma Fractionation Sales in Value by Region (2016-2021)
    • 3.2.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2016-2021)
  • 3.3 Global Blood Plasma Fractionation Forecasted Market Size by Region
    • 3.3.1 Global Blood Plasma Fractionation Sales in Volume by Region (2022-2027)
    • 3.3.2 Global Blood Plasma Fractionation Sales in Value by Region (2022-2027)
    • 3.3.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 BLOOD PLASMA FRACTIONATION BY APPLICATION

  • 4.1 Blood Plasma Fractionation Market Segment by Application
    • 4.1.1 Hospital
    • 4.1.2 Retail Pharmacy
  • 4.2 Global Blood Plasma Fractionation Market Size by Application
    • 4.2.1 Global Blood Plasma Fractionation Market Size Overview by Application (2016-2027)
    • 4.2.2 Global Blood Plasma Fractionation Historic Market Size Review by Application (2016-2021)
      • 4.2.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Application (2016-2021)
      • 4.2.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Application (2016-2021)
      • 4.2.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2016-2021)
    • 4.2.3 Global Blood Plasma Fractionation Forecasted Market Size by Application (2022-2027)
      • 4.2.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Application (2022-2027)
      • 4.2.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Application (2022-2027)
      • 4.2.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2022-2027)
  • 4.3 Key Regions Market Size Segment by Application
    • 4.3.1 North America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
    • 4.3.2 Europe Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
    • 4.3.3 Asia-Pacific Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
    • 4.3.4 South America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
    • 4.3.5 Middle East and Africa Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)

5 NORTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY

  • 5.1 North America Blood Plasma Fractionation Historic Market Size by Country
    • 5.1.1 North America Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
    • 5.1.2 North America Blood Plasma Fractionation Sales in Value by Country (2016-2021)
  • 5.2 North America Blood Plasma Fractionation Forecasted Market Size by Country
    • 5.2.1 North America Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
    • 5.2.2 North America Blood Plasma Fractionation Sales in Value by Country (2022-2027)

6 EUROPE BLOOD PLASMA FRACTIONATION BY COUNTRY

  • 6.1 Europe Blood Plasma Fractionation Historic Market Size by Country
    • 6.1.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
    • 6.1.2 Europe Blood Plasma Fractionation Sales in Value by Country (2016-2021)
  • 6.2 Europe Blood Plasma Fractionation Forecasted Market Size by Country
    • 6.2.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
    • 6.2.2 Europe Blood Plasma Fractionation Sales in Value by Country (2022-2027)

7 ASIA-PACIFIC BLOOD PLASMA FRACTIONATION BY REGION

  • 7.1 Asia-Pacific Blood Plasma Fractionation Historic Market Size by Region
    • 7.1.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2016-2021)
    • 7.1.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2016-2021)
  • 7.2 Asia-Pacific Blood Plasma Fractionation Forecasted Market Size by Region
    • 7.2.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2022-2027)
    • 7.2.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2022-2027)

8 SOUTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY

  • 8.1 South America Blood Plasma Fractionation Historic Market Size by Country
    • 8.1.1 South America Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
    • 8.1.2 South America Blood Plasma Fractionation Sales in Value by Country (2016-2021)
  • 8.2 South America Blood Plasma Fractionation Forecasted Market Size by Country
    • 8.2.1 South America Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
    • 8.2.2 South America Blood Plasma Fractionation Sales in Value by Country (2022-2027)

9 MIDDLE EAST AND AFRICA BLOOD PLASMA FRACTIONATION BY COUNTRY

  • 9.1 Middle East and Africa Blood Plasma Fractionation Historic Market Size by Country
    • 9.1.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
    • 9.1.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2016-2021)
  • 9.2 Middle East and Africa Blood Plasma Fractionation Forecasted Market Size by Country
    • 9.2.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
    • 9.2.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2022-2027)

10 COMPANY PROFILES AND KEY FIGURES IN BLOOD PLASMA FRACTIONATION BUSINESS

  • 10.1 Takeda
    • 10.1.1 Takeda Company Information
    • 10.1.2 Takeda Blood Plasma Fractionation Product Offered
    • 10.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.1.4 Takeda Main Business Overview
    • 10.1.5 Takeda Latest Developments
  • 10.2 CSL
    • 10.2.1 CSL Company Information
    • 10.2.2 CSL Blood Plasma Fractionation Product Offered
    • 10.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.2.4 CSL Main Business Overview
    • 10.2.5 CSL Latest Developments
  • 10.3 Grifols
    • 10.3.1 Grifols Company Information
    • 10.3.2 Grifols Blood Plasma Fractionation Product Offered
    • 10.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.3.4 Grifols Main Business Overview
    • 10.3.5 Grifols Latest Developments
  • 10.4 Octapharma
    • 10.4.1 Octapharma Company Information
    • 10.4.2 Octapharma Blood Plasma Fractionation Product Offered
    • 10.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.4.4 Octapharma Main Business Overview
    • 10.4.5 Octapharma Latest Developments
  • 10.5 Kedrion
    • 10.5.1 Kedrion Company Information
    • 10.5.2 Kedrion Blood Plasma Fractionation Product Offered
    • 10.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.5.4 Kedrion Main Business Overview
  • 10.6 LFB Group
    • 10.6.1 LFB Group Company Information
    • 10.6.2 LFB Group Blood Plasma Fractionation Product Offered
    • 10.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.6.4 LFB Group Main Business Overview
  • 10.7 Biotest
    • 10.7.1 Biotest Company Information
    • 10.7.2 Biotest Blood Plasma Fractionation Product Offered
    • 10.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.7.4 Biotest Main Business Overview
  • 10.8 BPL
    • 10.8.1 BPL Company Information
    • 10.8.2 BPL Blood Plasma Fractionation Product Offered
    • 10.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.8.4 BPL Main Business Overview
    • 10.8.5 BPL Latest Developments
  • 10.9 RAAS
    • 10.9.1 RAAS Company Information
    • 10.9.2 RAAS Blood Plasma Fractionation Product Offered
    • 10.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.9.4 RAAS Main Business Overview
    • 10.9.5 RAAS Latest Developments
  • 10.10 CBPO
    • 10.10.1 CBPO Company Information
    • 10.10.2 CBPO Blood Plasma Fractionation Product Offered
    • 10.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.10.4 CBPO Main Business Overview
    • 10.10.5 CBPO Latest Developments
  • 10.11 Hualan Bio
    • 10.11.1 Hualan Bio Company Information
    • 10.11.2 Hualan Bio Blood Plasma Fractionation Product Offered
    • 10.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.11.4 Hualan Bio Main Business Overview
  • 10.12 Tiantan Bio
    • 10.12.1 Tiantan Bio Corporation Information
    • 10.12.2 Tiantan Bio Blood Plasma Fractionation Products Offered
    • 10.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.12.4 Tiantan Bio Main Business Overview
  • 10.13 Shuanglin Bio
    • 10.13.1 Shuanglin Bio Corporation Information
    • 10.13.2 Shuanglin Bio Blood Plasma Fractionation Products Offered
    • 10.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.13.4 Shuanglin Bio Main Business Overview
  • 10.14 Boya Bio
    • 10.14.1 Boya Bio Corporation Information
    • 10.14.2 Boya Bio Blood Plasma Fractionation Products Offered
    • 10.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.14.4 Boya Bio Main Business Overview
  • 10.15 Yuanda Shuyang
    • 10.15.1 Yuanda Shuyang Corporation Information
    • 10.15.2 Yuanda Shuyang Blood Plasma Fractionation Products Offered
    • 10.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.15.4 Yuanda Shuyang Main Business Overview
  • 10.16 Weiguang Bio
    • 10.16.1 Weiguang Bio Corporation Information
    • 10.16.2 Weiguang Bio Blood Plasma Fractionation Products Offered
    • 10.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.16.4 Weiguang Bio Main Business Overview
  • 10.17 Nanyue Bio
    • 10.17.1 Nanyue Bio Corporation Information
    • 10.17.2 Nanyue Bio Blood Plasma Fractionation Products Offered
    • 10.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.17.4 Nanyue Bio Main Business Overview
  • 10.18 KM Biologics
    • 10.18.1 KM Biologics Corporation Information
    • 10.18.2 KM Biologics Blood Plasma Fractionation Products Offered
    • 10.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
    • 10.18.4 KM Biologics Main Business Overview
    • 10.18.5 KM Biologics Recent Development

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 11.1 Blood Plasma Fractionation Key Raw Materials
    • 11.1.1 Key Raw Materials
    • 11.1.2 Raw Materials Key Suppliers
  • 11.2 Manufacturing Cost Structure
    • 11.2.1 Raw Materials
    • 11.2.2 Labor Cost
    • 11.2.3 Manufacturing Expenses
  • 11.3 Manufacturing Process Analysis of Blood Plasma Fractionation
  • 11.4 Blood Plasma Fractionation Industrial Chain Analysis
  • 11.5 Blood Plasma Fractionation Market Dynamics
    • 11.5.1 Industry Trends
    • 11.5.2 Market Drivers
    • 11.5.3 Market Challenges
    • 11.5.4 Market Restraints

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

  • 12.1 Sales Channel
  • 12.2 Blood Plasma Fractionation Distributors
  • 12.3 Blood Plasma Fractionation Downstream Customers

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
      • 14.1.1.1 Research Programs/Design
      • 14.1.1.2 Market Size Estimation
      • 14.1.1.3 Market Breakdown and Data Triangulation
    • 14.1.2 Data Source
      • 14.1.2.1 Secondary Sources
      • 14.1.2.2 Primary Sources
  • 14.2 Author Details
  • 14.3 Disclaimer 148
Back to Top
전화 문의
F A Q